# Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites

> **NCT04234750** · PHASE1 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites

## Interventions

- **BIOLOGICAL:** mesenchymal stem cell conditioned medium-derived pleiotropic factor

## Key facts

- **NCT ID:** NCT04234750
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-17
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234750, "Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04234750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*